IFI-M · UAK Tri-Axis Balanced Series

Specimen SS-F-M3-02405 // MULTI-AXIS · IFI-M

UAK Tri-Axis Balanced Series I-NP

Solanum lycopersicum

Tomato

Tier IUAK Tri-Axis Balanced Series

Target Trait

1×

fold-change

Umami+Astringency+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02405

Genomic Edits

5

GC Content

48.5%

Construct Length

3,832 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

mGluR1 + Polyphenol-astringency axis + CaSR

IFI Score

100

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent UAK pathway operation
  • Cross-pathway regulatory circuit for balanced UAK triple-axis expression

Key Interventions

Triple-axis receptor co-activation: mGluR1, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (UAK) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I UAK triple-axis construct for advanced multi-modal sensory architecture combining umami, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$549 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities